Skip to main content
. 2021 Feb 16;14(2):159. doi: 10.3390/ph14020159

Figure 2.

Figure 2

FDG-PET after 4 weeks of treatment with dabrafenib and trametinib showed decreased FDG avidity. (a) FDG-PET performed in January; (b) FDG-PET performed in February 2016.